This inventor holds 2 USPTO granted patents. Top assignees: Baxter Healthcare Sa, Baxter International Inc., Other. Active years: 2003-2007.
Company Filing History:
1 out of 1,199 
1 out of 2,531 
1 out of 834,411 Years Active: 2003-2007
Title: Michael R Schick: Innovator in Hemoglobin Compositions
Introduction
Michael R Schick is a notable inventor based in Louisville, CO (US). He has made significant contributions to the field of hemoglobin compositions, holding 2 patents that focus on reducing side effects associated with therapeutic applications.
Latest Patents
His latest patents include innovative hemoglobin compositions that aim to eliminate or substantially reduce the creation of heart lesions, gastrointestinal discomfort, pressor effects, and endotoxin hypersensitivity. These recombinant mutant hemoglobin compositions have various applications, including treatments for anemia, head injury, hemorrhage or hypovolemia, ischemia, cachexia, sickle cell crisis, and stroke. Additionally, they enhance cancer treatments, stimulate hematopoiesis, improve the repair of physically damaged tissues, alleviate cardiogenic shock, and assist in shock resuscitation.
Career Highlights
Throughout his career, Michael has worked with prominent companies, including Baxter International Inc. His work has significantly impacted the medical field, particularly in developing safer hemoglobin-based therapies.
Collaborations
Michael has collaborated with notable individuals such as Douglas L Looker and Izydor Z Apostol, contributing to advancements in his field.
Conclusion
Michael R Schick's innovative work in hemoglobin compositions showcases his dedication to improving therapeutic applications and patient outcomes. His contributions continue to influence the medical community positively.